FiercePharmaOriginal article
{"a":[{"_":"Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat","$":{"href":"/pharma/bristol-myers-delays-cobenfy-alzheimers-psychosis-readout-again-amid-another-quarterly-beat","hreflang":"en"}}]}
Data ReadoutCobenfymilvexianNegative
AI Analysis
Summary
Bristol Myers Squibb has delayed the readout of its Cobenfy Alzheimer's psychosis trial and milvexian atrial fibrillation data, with no new timeline disclosed in the article.
Outcome Details
Readout delayed
Importance:6/10
Sentiment:
-0.30
delayCobenfyAlzheimer'sdata readoutmilvexianatrial fibrillation
Related Companies
Read the original article
Published by FiercePharma on July 30, 2026 9:43 AM
